Default company panoramic image
45529ed1 978b 4a0b 894b 904a02676bdf

Neuronascent, Inc.

Neuronascent has discovered and is developing novel, noninvasive “neurorestorative” therapeutics for Alzheimer's and other CNS disorders

  • Stage Product In Development
  • Industry Biotechnology
  • Location Clarksville, MD, USA
  • Currency USD
  • Founded May 2004
  • Employees 2
  • Website neuronascent.com

Company Summary

Neuronascent (NNI), founded by Dr. Kelleher-Andersson began operations in 2005. Through NNI's phenotypic screening platform agents were identified that promote mature new neurons. Patents covering NNI's oral therapies are issued. NNI-362, an Alzheimer's candidate has shown reversal of cognitive deficits correlating to increased new neurons in animal models. NNI aims to quickly complete FDA-mandated safety studies with continued support of NIA.

Team

  • Default avatar
    Judith Kelleher-Andersson
    President, CSO

  • Default avatar
    Kathleen Mattis
    CFO and Secretary

Advisors

  • Default avatar
    Cooley Godward Kronish (bus dev), Wilmer Hale (patent)
    Lawyer
    Unconfirmed
    Default avatar
    n/a
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Jefferson Corner Group
    Unconfirmed